financetom
Business
financetom
/
Business
/
Softchoice Announced Renewal of Normal Course Issuer Bid
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Softchoice Announced Renewal of Normal Course Issuer Bid
Mar 8, 2024 5:14 AM

07:58 AM EST, 03/08/2024 (MT Newswires) -- Softchoice Corporation ( SFTCF ) on Friday announced that the TSX has accepted its notice of intention to renew its normal course issuer bid.

Softchoice ( SFTCF ) may purchase up to 1.5 million of its shares, approximately 2.5% of its issued and outstanding shares, from March 13, and ending March 12 next year.

The company's prior NCIB will expire on March 12. Under this NCIB, as of February 29, Softchoice ( SFTCF ) purchased 423,409 shares at a weighted average price of $16.78 each, for a total consideration of $7.1 million.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Personal defense products maker Byrna's Q3 revenue rises 35%
Personal defense products maker Byrna's Q3 revenue rises 35%
Oct 9, 2025
Overview * Byrna ( BYRN ) fiscal Q3 revenue grows 35% yr/yr to $28.2 mln * Adjusted EBITDA for fiscal Q3 nearly doubles from previous year * Net income for fiscal Q3 rises to $2.2 mln from $1.0 mln a year earlier Outlook * Byrna ( BYRN ) expects fiscal 2025 revenue growth of 35-40% * Company anticipates strong holiday...
BRIEF-Mergerware Collaborates With Mercer To Redefine M&A Deal Execution
BRIEF-Mergerware Collaborates With Mercer To Redefine M&A Deal Execution
Oct 9, 2025
Oct 9 (Reuters) - Marsh & McLennan Companies Inc ( MMC ) : * MERGERWARE COLLABORATES WITH MERCER TO REDEFINE M&A DEAL EXECUTION Source text: Further company coverage: ...
Telomir Pharmaceuticals Says Telomir-1 Significantly Reduces Survival of Triple-Negative Breast Cancer Cells
Telomir Pharmaceuticals Says Telomir-1 Significantly Reduces Survival of Triple-Negative Breast Cancer Cells
Oct 9, 2025
08:03 AM EDT, 10/09/2025 (MT Newswires) -- Telomir Pharmaceuticals ( TELO ) said Thursday that its laboratory studies show that Telomir-1 significantly reduces the survival of aggressive triple-negative breast cancer cells. The company said it plans to expand its findings by testing additional cancer types and conducting further animal studies to prepare for an investigational new drug submission. The company's...
Spanish court summons Gotham City founder in Grifols share price probe
Spanish court summons Gotham City founder in Grifols share price probe
Oct 9, 2025
MADRID, Oct 9 (Reuters) - Spain's High Court on Thursday summoned the founder of U.S.-based short seller Gotham City Research, Daniel Yu, to testify over allegations his company disseminated misleading information about pharma firm Grifols to influence its share price. In January 2024, Gotham City, which had previously shorted Grifols shares, released a report accusing the company of overstating earnings...
Copyright 2023-2026 - www.financetom.com All Rights Reserved